 Connection
Masanori Hayashi to Follow-Up Studies
This is a "connection" page, showing publications Masanori Hayashi has written about Follow-Up Studies.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.050 |
|
|
|
-
Kato H, Ochi K, Hara Y, Kurimoto S, Tsuruta T, Tajiri Y, Kitamura Y, Tazaki K, Kodama N, Yasunaga H, Ikegami S, Ikeda K, Nishiwaki M, Amako M, Osada R, Okazaki M, Tanaka H, Kobayashi Y, Omokawa S, Hidaka N, Morisawa Y, Kato N, Tada K, Asami A, Tashima H, Hayashi M, Uchiyama S, Horiuchi Y. Clinical characteristics and results after conservative treatment or interfascicular neurolysis of 58 limbs with spontaneous posterior interosseous nerve palsy: A prospective Japanese multicenter study. J Orthop Sci. 2026 Sep; 31(5):1036-1044.
Score: 0.030
-
Oesterheld JE, Reed DR, Setty BA, Isakoff MS, Thompson P, Yin H, Hayashi M, Loeb DM, Smith T, Makanji R, Fridley BL, Wagner LM. Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatr Blood Cancer. 2020 07; 67(7):e28370.
Score: 0.020
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|